Dr. Fabian Filipp Identifies Master Regulators and New Drug Targets in Therapy-Resistant Cancer
New research published today in the Nature Partner journal npj Systems Biology and Applications establishes how genome-wide data in combination with systems biology analyses can identify master regulators and new drug targets in therapy-resistant cancers.
The new discovery explains how cancer controls specific effector networks — findings with important implications for the future of cancer therapy.